Orcimont L 4mg/2.5mg Tablet
By Orcimont L
Rx
10 Tablet in a Strip

Composition
Levocetirizine(4mg) + Montelukast(2.5mg)

Manufacturer - Iva Healthcare Pvt. Ltd.
Iva Healthcare Private Limited, Manish Bansal(Director), Plot No. 400, Industrial Area, Phase 1, Panchkula - 134113, Haryana, India

Expires on or after
April, 2027

liver
Orcimont L 4mg/2.5mg Tablet should be used carefully in individuals with severe liver disease. It may be necessary to adjust the dosage of Orcimont L 4mg/2.5mg Tablet in these cases, so consulting your doctor is essential. There is limited data on the use of Orcimont L 4mg/2.5mg Tablet in patients with severe liver issues. However, no dosage adjustment is suggested for those with mild to moderate liver disease.

kidney
Orcimont L 4mg/2.5mg Tablet should be used carefully in patients with kidney disease. Adjusting the dose may be necessary, so it's important to consult your doctor. Avoid using this tablet in cases of severe kidney disease.

alcohol
When taking Orcimont L 4mg/2.5mg Tablet, it is important to be cautious when consuming alcohol. It is recommended to consult your doctor about alcohol intake.

driving
Orcimont L 4mg/2.5mg Tablet may reduce alertness, impact vision, and cause drowsiness and dizziness. Avoid driving if experiencing these effects.

pregnancy
Orcimont L 4mg/2.5mg Tablet is generally considered safe during pregnancy. Animal studies show limited adverse effects, but human studies are lacking.

breastfeeding
Orcimont L 4mg/2.5mg Tablet should be avoided during breastfeeding as it may potentially harm the baby. Please consult your healthcare provider for safer alternatives.
Habit Forming | No |
Chemical Class | - |
Therapeutic Class | RESPIRATORY |
Action Class | - |
₹105
Inclusive of all taxes
Content verified by

Dr. Archana Prabhakar
MBBS, M.Med (Family Medicine)
Last update on 01-Oct-2024